Investment Type: Venture Capital
Mentions in press and media 1
| Date | Title | Description | Source |
| 13.11.2018 | Kymera Therapeutics Announces $65 Million Series B | Kymera Therapeutics Inc., a biotechnology company pioneering targeted protein degradation to create ... | citybizlis... |